Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical Letter: A case report of targeted therapy with sirolimus for NPRL3 epilepsy

3 Nov 2019

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genetic and Kidney Cyst Diseases
Share to PI3K/AKT/mTOR signaling in cancer
Share to Tuberous Sclerosis Complex Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 31733420
DOI: 10.1016/j.seizure.2019.10.007

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical Letter: A case report of targeted therapy with sirolimus for NPRL3 epilepsyPMID 31733420Read ↗

Topical Review: Intractable Seizures in Tuberous Sclerosis Complex: From Molecular Pathogenesis to the Rationale for TreatmentSemantic proximity Read ↗

mTOR-therapy and targeted treatment opportunities in mTOR-related epilepsies associated with cortical malformationsSemantic proximity Read ↗

Tuberous sclerosis complex: a review of the management of epilepsy with emphasis on surgical aspectsSemantic proximity Read ↗

Commentary: GATOR Complex-Associated Epilepsies.Semantic proximity Read ↗

Epilepsy.Semantic proximity Read ↗

Circulating miRNAs expression profiling in drug-resistant epilepsy: Up-regulation of miR-301a-3p in a case of sudden unexpected deathSemantic proximity Read ↗

Drug Resistance in Epilepsy: Clinical Impact, Potential Mechanisms, and New Innovative Treatment OptionsSemantic proximity Read ↗

Targeting epilepsy genes.Semantic proximity Read ↗

BRAF inhibition efficacy in drug-refractory epilepsySemantic proximity Read ↗

Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complexSemantic proximity Read ↗

Recent Advances and Challenges of mTOR Inhibitors Use in the Treatment of Patients with Tuberous Sclerosis ComplexSemantic proximity Read ↗

[Drug resistant epilepsy. Clinical and neurobiological concepts].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.